Q1 Revenue Prediction, page-11

Based just on a few of the rather bullish comments of Paul Hyslop in the FY results, I go for at least 25Mil.

"Strong sales came from Australia and New Zealand in both the B2B and B2C markets. UK and Europe continue to deliver and, in Asia and China, we are making good progress. We have also recently bought back the US distributor and will be seeking to mirror the success of the UK operations in this region." "Progress in the Middle East, Africa, Turkey, India, Pakistan and Bangladesh has similarly been made with several new distribution agreements. Zoono is becoming a true global company in the provision of antimicrobial protection." Importantly, sales into the veterinary and animal health sector continue to grow. We expect this to continue and for this sector to materially contribute to the Company’s revenues going forward"